Isakson, Sara H.
Rizzardi, Anthony E.
Coutts, Alexander W.
Carlson, Daniel F.
Kirstein, Mark N.
Fisher, James
Vitte, Jeremie http://orcid.org/0000-0002-2567-7988
Williams, Kyle B.
Pluhar, G. Elizabeth
Dahiya, Sonika
Widemann, Brigitte C.
Dombi, Eva
Rizvi, Tilat
Ratner, Nancy
Messiaen, Ludwine
Stemmer-Rachamimov, Anat O.
Fahrenkrug, Scott C.
Gutmann, David H.
Giovannini, Marco
Moertel, Christopher L.
Largaespada, David A.
Watson, Adrienne L.
Funding for this research was provided by:
Children's Tumor Foundation (Synodos for NF1)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1-R35-NS07211-01)
Article History
Received: 30 April 2018
Accepted: 7 September 2018
First Online: 2 October 2018
Competing interests
: A.L.W., T.R., A.W.C., D.F.C., S.C.F., and D.A.L. are employees and/or shareholders of Recombinetics Inc. C.L.M. is a consultant to Recombinetics Inc. The remaining authors declare no competing interests.